Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Randomised, double-blind, placebo controlled, cross-over study comparing the effects of both single dose and repeated dosing treatment for 14 days of vestipitant or vestipitant / paroxetine combination in an enriched population of subjects with tinnitus & hearing loss
vestipant;vestipitant/paroxetine
NKP106254
NCT00394056
Tinnitus
Phase 2
 
An annotated and blank case report form are not available as the electronic data capture system used for this study did not generate paper versions.
November 2014

Powered by ideaPoint, Inc.